Sildenafil Improves Vascular and Metabolic Function in Patients with Alzheimer's Disease.

BACKGROUND Alzheimer's disease (AD) is the leading cause of degenerative dementia in the aging population. Patients with AD have alterations in cerebral hemodynamic function including reduced cerebral blood flow (CBF) and cerebral metabolic rate. Therefore, improved cerebrovascular function may be an attractive goal for pharmaceutical intervention in AD. OBJECTIVE We wished to observe the acute effects of sildenafil on cerebrovascular function and brain metabolism in patients with AD. METHODS We used several novel non-invasive MRI techniques to investigate the alterations of CBF, cerebral metabolic rate of oxygen (CMRO2), and cerebrovascular reactivity (CVR) after a single dose of sildenafil administration in order to assess its physiological effects in patients with AD. CBF, CMRO2, and CVR measurements using MRI were performed before and one hour after the oral administration of 50 mg sildenafil. Baseline Montreal Cognitive Assessment score was also obtained. RESULTS Complete CBF and CMRO2 data were obtained in twelve patients. Complete CVR data were obtained in eight patients. Global CBF and CMRO2 significantly increased (p = 0.03, p = 0.05, respectively) following sildenafil administration. Voxel-wise analyses of CBF maps showed that increased CBF was most pronounced in the bilateral medial temporal lobes. CVR significantly decreased after administration of sildenafil. CONCLUSION Our data suggest that a single dose of sildenafil improves cerebral hemodynamic function and increases cerebral oxygen metabolism in patients with AD.

[1]  R. Nicoll.  A Brief History of Long-Term Potentiation , 2017, Neuron.

[2]  D. Bredesen,et al.  sAβPPα is a Potent Endogenous Inhibitor of BACE1. , 2015, Journal of Alzheimer's disease : JAD.

[3]  W. Seeger,et al.  Sildenafil Improves Dynamic Vascular Function in the Brain: Studies in Patients with Pulmonary Hypertension , 2006, Cerebrovascular Diseases.

[4]  Yang Li,et al.  Cerebrovascular reactivity mapping without gas challenges , 2017, NeuroImage.

[5]  B. Nossaman,et al.  Nitrates and Nitrites in the Treatment of Ischemic Cardiac Disease , 2010, Cardiology in Review.

[6]  E. Rostrup,et al.  Cerebral Haemodynamic Response or Excitability is not Affected by Sildenafil , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  M. Nieto,et al.  Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice , 2004, Neuroscience.

[8]  M. Chopp,et al.  Angiogenesis and improved cerebral blood flow in the ischemic boundary area detected by MRI after administration of sildenafil to rats with embolic stroke , 2007, Brain Research.

[9]  M. Rattray,et al.  Chronic hypoxia in the human neuroblastoma SH-SY5Y causes reduced expression of the putative α-secretases, ADAM10 and TACE, without altering their mRNA levels , 2006, Brain Research.

[10]  M. Chopp,et al.  Delayed treatment with sildenafil enhances neurogenesis and improves functional recovery in aged rats after focal cerebral ischemia , 2006, Journal of neuroscience research.

[11]  J. Olesen,et al.  The Phosphodiesterase 5 Inhibitor Sildenafil Has No Effect on Cerebral Blood Flow or Blood Velocity, but Nevertheless Induces Headache in Healthy Subjects , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  Sudha Seshadri,et al.  Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease , 2002 .

[13]  B. Allinquant,et al.  Functions of Aβ, sAPPα and sAPPβ : similarities and differences , 2012, Journal of neurochemistry.

[14]  J. Olesen,et al.  Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. , 2003, Brain : a journal of neurology.

[15]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[16]  C. Peers,et al.  Altered processing of amyloid precursor protein in the human neuroblastoma SH‐SY5Y by chronic hypoxia , 2002, Journal of neurochemistry.

[17]  D. Madison,et al.  A requirement for the intercellular messenger nitric oxide in long-term potentiation. , 1991, Science.

[18]  Philip S. Insel,et al.  Brain Amyloid-β Burden Is Associated with Disruption of Intrinsic Functional Connectivity within the Medial Temporal Lobe in Cognitively Normal Elderly , 2015, The Journal of Neuroscience.

[19]  A. Blokland,et al.  cGMP, but not cAMP, in rat hippocampus is involved in early stages of object memory consolidation. , 2002, European journal of pharmacology.

[20]  John A. Detre,et al.  Temporal Dynamics of Brain Tissue Nitric Oxide during Functional Forepaw Stimulation in Rats , 2003, NeuroImage.

[21]  T. Bliss,et al.  Expression of NMDA receptor-dependent LTP in the hippocampus: bridging the divide , 2013, Molecular Brain.

[22]  Peiying Liu,et al.  Test–retest reproducibility of a rapid method to measure brain oxygen metabolism , 2013, Magnetic resonance in medicine.

[23]  C. McAdams,et al.  Automatic and Reproducible Positioning of Phase-Contrast MRI for the Quantification of Global Cerebral Blood Flow , 2014, PloS one.

[24]  M. Boccia,et al.  Effects of sildenafil on long-term retention of an inhibitory avoidance response in mice. , 1999, Behavioural pharmacology.

[25]  James T Becker,et al.  Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging. , 2009, Radiology.

[26]  A. Hofman,et al.  Non-insulin-dependent Diabetes Mellitus (niddm) Association of Diabetes Mellitus and Dementia: the Rotterdam Study , 2022 .

[27]  J. Lanciego,et al.  Tadalafil crosses the blood–brain barrier and reverses cognitive dysfunction in a mouse model of AD , 2013, Neuropharmacology.

[28]  A. Blokland,et al.  Dissociable effects of acetylcholinesterase inhibitors and phosphodiesterase type 5 inhibitors on object recognition memory: acquisition versus consolidation , 2004, Psychopharmacology.

[29]  A. Palmeri,et al.  Phosphodiesterase 5 Inhibition Improves Synaptic Function, Memory, and Amyloid-β Load in an Alzheimer's Disease Mouse Model , 2009, The Journal of Neuroscience.

[30]  Hanzhang Lu,et al.  Quantitative evaluation of oxygenation in venous vessels using T2‐Relaxation‐Under‐Spin‐Tagging MRI , 2008, Magnetic resonance in medicine.

[31]  Victoria P. A. Johnstone,et al.  A protein synthesis and nitric oxide-dependent presynaptic enhancement in persistent forms of long-term potentiation. , 2011, Learning & memory.

[32]  A. Salminen,et al.  Hypoxia/ischemia activate processing of Amyloid Precursor Protein: impact of vascular dysfunction in the pathogenesis of Alzheimer's disease , 2017, Journal of neurochemistry.

[33]  G. Bernardi,et al.  Sildenafil increases cerebrovascular reactivity: A transcranial Doppler study , 2005, Neurology.

[34]  Hanzhang Lu,et al.  Noninvasive quantification of whole‐brain cerebral metabolic rate of oxygen (CMRO2) by MRI , 2009, Magnetic resonance in medicine.

[35]  D. Dickson,et al.  Inducible nitric oxide synthase immunoreactivity in the Alzheimer disease hippocampus: association with Hirano bodies, neurofibrillary tangles, and senile plaques. , 1999, Journal of neuropathology and experimental neurology.

[36]  N. Emptage,et al.  Two sides to long-term potentiation: a view towards reconciliation , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

[37]  H. Vinters,et al.  Effects of Anoxia and Hypoxia on Amyloid Precursor Protein Processing in Cerebral Microvascular Smooth Muscle Cells , 2006, Journal of neuropathology and experimental neurology.

[38]  A. Blokland,et al.  Phosphodiesterase type 5 inhibition improves early memory consolidation of object information , 2004, Neurochemistry International.

[39]  P. Kelly,et al.  Phosphodiesterase Inhibitors Enhance Object Memory Independent of Cerebral Blood Flow and Glucose Utilization in Rats , 2009, Neuropsychopharmacology.

[40]  Peiying Liu,et al.  Calibration and validation of TRUST MRI for the estimation of cerebral blood oxygenation , 2012, Magnetic resonance in medicine.

[41]  T. Arendt,et al.  Aberrant expression of NOS isoforms in Alzheimer’s disease is structurally related to nitrotyrosine formation , 2002, Brain Research.

[42]  Masayuki Yamamoto,et al.  Protein S-guanylation by the biological signal 8-nitroguanosine 3',5'-cyclic monophosphate. , 2007, Nature chemical biology.

[43]  S. Kety,et al.  THE EFFECTS OF ALTERED ARTERIAL TENSIONS OF CARBON DIOXIDE AND OXYGEN ON CEREBRAL BLOOD FLOW AND CEREBRAL OXYGEN CONSUMPTION OF NORMAL YOUNG MEN. , 1948, The Journal of clinical investigation.

[44]  G. Zaharchuk,et al.  Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. , 2015, Magnetic resonance in medicine.

[45]  Xavier Golay,et al.  Measurement of tissue oxygen extraction ratios from venous blood T2: Increased precision and validation of principle , 2001, Magnetic resonance in medicine.

[46]  A. Heerschap,et al.  Hypertension Impairs Cerebral Blood Flow in a Mouse Model for Alzheimer's Disease. , 2015, Current Alzheimer research.

[47]  A. Takashima,et al.  Modification of Tau by 8-Nitroguanosine 3′,5′-Cyclic Monophosphate (8-Nitro-cGMP) , 2016, The Journal of Biological Chemistry.

[48]  Bojana Stefanovic,et al.  Amyloid-β-dependent compromise of microvascular structure and function in a model of Alzheimer's disease. , 2012, Brain : a journal of neurology.

[49]  P. Ewert,et al.  Influence of Intravenous Sildenafil on Cerebral Oxygenation Measured by Near-Infrared Spectroscopy in Infants After Cardiac Surgery , 2006, Pediatric Research.

[50]  Tom F. Lue,et al.  Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. , 1998, New England Journal of Medicine.

[51]  M. Chopp,et al.  Functional Recovery in Aged and Young Rats After Embolic Stroke: Treatment With a Phosphodiesterase Type 5 Inhibitor , 2005, Stroke.

[52]  Hong Qing,et al.  Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression , 2006, Proceedings of the National Academy of Sciences.

[53]  Feng Xu,et al.  Estimation of labeling efficiency in pseudocontinuous arterial spin labeling , 2010, Magnetic resonance in medicine.

[54]  S. Finklestein,et al.  Phosphodiesterase 5A Inhibitors Improve Functional Recovery after Stroke in Rats: Optimized Dosing Regimen with Implications for Mechanism , 2009, Journal of Pharmacology and Experimental Therapeutics.

[55]  D Wyper,et al.  Measurements of regional cerebral blood flow and cognitive performance in Alzheimer's disease. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[56]  R. Franco,et al.  Sildenafil restores cognitive function without affecting β‐amyloid burden in a mouse model of Alzheimer's disease , 2011, British journal of pharmacology.

[57]  M. Chopp,et al.  Sildenafil (Viagra) Induces Neurogenesis and Promotes Functional Recovery After Stroke in Rats , 2002, Stroke.

[58]  Olga Pletnikova,et al.  Effect of infarcts on dementia in the Baltimore longitudinal study of aging , 2008, Annals of neurology.

[59]  A. Blokland,et al.  The selective PDE5 inhibitor, sildenafil, improves object memory in Swiss mice and increases cGMP Levels in hippocampal slices , 2005, Behavioural Brain Research.

[60]  T. Fleming,et al.  Sildenafil citrate therapy for pulmonary arterial hypertension. , 2005, The New England journal of medicine.

[61]  Thomas Wisniewski,et al.  Clearance systems in the brain—implications for Alzheimer disease , 2015, Nature Reviews Neurology.

[62]  M. Raichle,et al.  What is the Correct Value for the Brain-Blood Partition Coefficient for Water? , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[63]  B. Zlokovic.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.

[64]  Jinsoo Uh,et al.  Forebrain-dominant deficit in cerebrovascular reactivity in Alzheimer's disease , 2012, Neurobiology of Aging.

[65]  D. Alsop,et al.  Continuous flow‐driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields , 2008, Magnetic resonance in medicine.

[66]  Guanghua Xiao,et al.  On the assessment of cerebrovascular reactivity using hypercapnia BOLD MRI , 2009, NMR in biomedicine.

[67]  M. Perry,et al.  Chemotherapeutic potential of phosphodiesterase inhibitors. , 1998, Current opinion in chemical biology.

[68]  Sina Aslan,et al.  On the sensitivity of ASL MRI in detecting regional differences in cerebral blood flow. , 2010, Magnetic resonance imaging.

[69]  Michael Chopp,et al.  Magnetic Resonance Imaging Investigation of Axonal Remodeling and Angiogenesis after Embolic Stroke in Sildenafil-Treated Rats , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[70]  A. Palmeri,et al.  Amyloid-β Peptide Inhibits Activation of the Nitric Oxide/cGMP/cAMP-Responsive Element-Binding Protein Pathway during Hippocampal Synaptic Plasticity , 2005, The Journal of Neuroscience.

[71]  E. Kandel,et al.  Nitric Oxide Acts Directly in the Presynaptic Neuron to Produce Long-Term Potentiationin Cultured Hippocampal Neurons , 1996, Cell.

[72]  Joep Lagro,et al.  Impaired cerebral autoregulation and vasomotor reactivity in sporadic Alzheimer's disease. , 2014, Current Alzheimer research.

[73]  A. Blokland,et al.  Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat , 2002, Neuroscience.

[74]  C. Colton,et al.  NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease , 2006, Proceedings of the National Academy of Sciences.

[75]  David M Holtzman,et al.  Cerebrovascular Dysfunction in Amyloid Precursor Protein Transgenic Mice: Contribution of Soluble and Insoluble Amyloid-β Peptide, Partial Restoration via γ-Secretase Inhibition , 2008, The Journal of Neuroscience.

[76]  Peiying Liu,et al.  MRI Mapping of Cerebrovascular Reactivity via Gas Inhalation Challenges , 2014, Journal of visualized experiments : JoVE.

[77]  A. Hofman,et al.  Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study , 1998, The Lancet.

[78]  Jing Jing Li,et al.  Differential regulation of BACE1 expression by oxidative and nitrosative signals , 2011, Molecular Neurodegeneration.

[79]  J. Jordán,et al.  Sildenafil ameliorates cognitive deficits and tau pathology in a senescence-accelerated mouse model , 2012, Neurobiology of Aging.

[80]  H. Steinbusch,et al.  Species differences in the localization of cGMP‐producing and NO‐responsive elements in the mouse and rat hippocampus using cGMP immunocytochemistry , 2004, The European journal of neuroscience.

[81]  Rong Zhang,et al.  Altered cerebral hemodynamics in early Alzheimer disease: a pilot study using transcranial Doppler. , 2009, Journal of Alzheimer's disease : JAD.

[82]  K. Weissenborn,et al.  Effect of sildenafil (Viagra®) on cerebral blood flow velocity: a pilot study , 2003, Psychiatry Research: Neuroimaging.